News & Insights
The Hidden Cost of Payment Disputes: Why Site Payment Accuracy Is a Study Start-Up
In clinical research, site payment disputes are commonly treated as a back-office problem. That is, something to resolve quietly between finance teams after the trial is underway. In practice, however,
Electronic vs. Digital vs. Wet-Ink Signatures in Clinical Trials
Why It’s More Complex Than It Sounds One common (and underestimated) source of delay in clinical trial agreements isn’t negotiation but execution. Everyone says: “Just send it via DocuSign.”
Clinical Trials in England: What Sponsors & CROs Need to Know for 2026
The landscape for clinical trials in England is shifting gears as we move through 2026. If you are a Sponsor or a CRO, the new regulatory focus on the National
Turkish Data Protection Law: Critical Compliance Requirements for Foreign Clinical Trial Sponsors
Interested in clinical trial sites in Turkey as a foreign Sponsor? This article is critical in understanding a major risk for compliance with their data protection law. If you do
Planning Ahead: Data Protection as a Critical Path in Clinical Trial Start-Up
Aligning Roles, Vendors, and Informed Consent Before the Clock Starts Introduction Data protection compliance is increasingly recognized as a critical path activity in clinical trial start-up, yet it
From Bottlenecks to Breakthroughs: Rethinking Site Contract Negotiations
In clinical research, few processes impact timelines more than site contract negotiations. Yet too often, negotiations are treated as isolated transactions rather than as part of a broader operational system.